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Abstract 
In patients with artificial joints, the need for antimicrobial prophylaxis during dental procedures is 
often raised. The present document describes the pathogenic mechanisms and epidemiological 
data on the subject of periprosthetic joint infections (PJI) after dental procedures. The document 
reflects the opinion and recommendations of the expert group ‘Infection’ of Swiss Orthopaedics.  
Microorganisms belonging to oral flora can seed haematogenously to an artificial joint. The proof 
of a causative relation with dental procedures is not possible, because the responsible bacteraemia 
can originate from the oral cavity at any time, irrespective of when the dental procedure occurs. 
Good oral hygiene is associated with a lower risk for PJI. Transient bacteraemia occurs during daily 
oral hygiene activity (e.g., tooth brushing) and thus the cumulative risk for a haematogenous PJI 
from tooth brushing is higher than that from a dental procedure. PJI after a dental procedure are 
rarely reported. On the basis of an epidemiological model, several thousand patients with artificial 
joints must receive antimicrobial prophylaxis to prevent a single PJI. Considering this ratio, the 
number of adverse events due to the antimicrobial compound exceeds the benefit of administering 
it by a large magnitude. Therefore, as a rule for the vast majority of cases, antimicrobial prophylaxis 
during dental procedures is not recommended. It is important that a patient has a good oral health 
status before joint implantation and that good oral hygiene is continuously maintained in patients 
with artificial joints. 
Key words: periprosthetic joint infections, antimicrobial prophylaxis, dental procedure. 
Introduction 
Dentists and general practitioners often ask 
orthopaedic surgeons and infectious diseases 
specialists whether or not a patient with arthroplasty 
should have antimicrobial prophylaxis during dental 
procedures, dental interventions or dental hygiene 
treatment. In 2008, Uçkay et al. [1] summarized the 
evidence in answer to this question. Numerous 
recommendations have been published from various 
professional societies in different countries 
(supplementary material: Table S1). However, 
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observations from clinical practice and surveillance 
studies [2] demonstrate a divergence between these 
recommendations and their translation into patient 
management [3, 4]. On the one hand, a statement by 
one working group [5] may be followed by a 
contradictory statement by another group [6], leading 
to confusion [7]. On the other, professional societies 
sometimes use wording in their recommendations 
that is correct from a legal perspective (i.e., ‘not 
attackable’), but which may nonetheless be unhelpful 
in clinical practice (supplementary material: Table 
S1). Moreover, as the number of patients with 
multiple comorbidities grows, so too does a frail 
population with increased risk for complications 
during anaesthesia and orthopaedic surgery. 
Understandably, responsible dentists and physicians 
have an interest in avoiding infection, in particular in 
this group of patients. This document reviews the 
pathogenic mechanisms and epidemiological 
reasoning behind haematogenous seeding of artificial 
joints from oral flora, and it provides Swiss 
recommendations for antimicrobial prophylaxis 
during dental procedures for patients with artificial 
joints.  
Dental examination prior to implantation 
of a prosthetic joint 
A dental examination prior to implantation of an 
arthroplasty is recommended. The extent and details 
of such an examination cannot uniformly be defined, 
because they depend on the patient’s oral health 
status and his oral hygiene practices. Nevertheless, 
the goal of such an examination includes the detection 
and treatment of potential infection sources prior to 
implantation of foreign body material. In addition, a 
patient’s oral health status can be judged and the 
importance of continuous maintenance of good oral 
hygiene emphasized (Table 1).  
It is important to note that this recommendation 
should be interpreted with a justifiable view of 
differentiation. Patients with an already existing good 
oral health status and regular dental visits may not 
benefit from an additional examination shortly prior 
to implantation of an arthroplasty. The awareness of 
the importance, and hence, the average level of the 
oral health status in a population may differ between 
countries. Similarly, cost coverage of dental 
examinations and interventions vary between 
different health care systems. To the best of our 
knowledge, there are no cost-effectiveness studies 
examining the role of dental examinations in reducing 
the incidence of periprosthetic joint infections (PJIs). 
Nonetheless, we are convinced that patients with poor 
oral health status and remote infection foci in the oral 
cavity may benefit from this recommendation. 
Antimicrobial treatment of an apical 
periodontitis or an abscess  
It is important to differentiate whether the dental 
procedure is being performed in a patient because of 
an infection in the oral cavity (e.g., an apical 
periodontitis or an abscess) or in a patient without an 
infection. For the former case, we discuss 
‘antimicrobial treatment’ (see next paragraph). For the 
latter case, we evaluate the necessity of ‘antimicrobial 
prophylaxis’ (subject of this document).  
In patients without an arthroplasty, in the case of 
apical periodontitis or abscess, the benefit of systemic 
antibiotics after a dental procedure is unclear [8]. Such 
cases may be treated without antibiotics. Therefore, 
we recommend differentiating between patients with 
and without arthroplasties. In patients with artificial 
joints, treatment of infections is recommended with 
systemic antibiotics (amoxicillin/clavulanate 1 g or – 
in patients with known allergy to penicillin – 
clindamycin 600 mg three times per day for 3 to 5 
days; then evaluation of the disease course and 
decision to stop or continue treatment). This 
recommendation is not based on existing evidence, 
but on reasoning regarding the pathogenic 
mechanism. In the case of an abscess, the bacterial 
load is hypothesized to be high. In the same line of 
Table 1. Recommendation of antibiotic use during dental procedure prior to and after implantation of an arthroplasty. 
Dental procedure  
Prior to implantation of an arthroplasty Systemic antimicrobial prophylaxis 
Dental examination (including panoramic radiograph)  
All dental diseases should be treated prior to implantation of an arthroplasty 
Coordinate dental examinations on a regular basis for the time after implantation of an arthroplasty 
No 
After implantation of an arthroplasty without an infection in the oral cavity Systemic antimicrobial prophylaxis 
Good oral hygiene, regular dental examinations in reasonable time intervals No 
All dental procedures/interventions (including tooth extraction, dental root canal treatment) 
without multiple risk factors (Table 2):  mouth rinse with 0.2% chlorhexidine 
No 
After implantation of an arthroplasty with an infection in the oral cavity 
(e.g., apical periodontitis or abscess) 
Antimicrobial treatment 
Rapid dental/oral surgical treatment Amoxicillin/clavulanate 1 g three times daily OR 
Clindamycin 600 mg three times daily for 3 to 5 days*  
*After 3 to 5 days of antimicrobial treatment, clinical re-evaluation and decision making regarding continuing or stopping antimicrobial treatment.  Recommended dose  for 
normal body weigh with adequate liver and renal function. 
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reasoning, the dental procedure for an abscess is 
assumed to trigger bacteraemia, and the bacterial load 
within this kind of bacteraemia is thought to be higher 
than can be expected during a dental procedure for 
non-infectious causes. On the basis of these 
arguments, the risk for haematogenous seeding to an 
artificial joint would be higher. In an animal 
foreign-body infection model, a bacterial load of 100 
to 1000 colony forming units of Staphylococcus aureus 
per milliliter of blood caused a haematogenous 
infection of an extravascular implant [9]. Such a 
bacterial load with this bacterial species is not 
expected during a routine dental procedure, although 
it is conceivable that the bacterial load is higher in the 
case of an abscess in the oral cavity.  
Theoretic relationship between dental 
procedures and PJI  
Asymptomatic bacteraemia can occur shortly 
after dental root treatment (31%-54% of patients in 
[10]). Consequently, the potential exists for 
haematogenous seeding to an artificial joint. Case 
reports have demonstrated identical clones of 
microorganisms isolated from samples in synovial 
fluid and dental plaques [11]. From this pathogenesis, 
these reports suggest a relationship between dental 
procedures and PJI. The microorganisms in these 
cases belong to those commonly found in the oral 
flora [1, 12-16]. Although these arguments strongly 
point to the source of haematogenous seeding, they 
cannot ascertain ‘when’ the responsible bacteraemia 
occurred: it may have occurred without a dental 
procedure [16]. Asymptomatic transient bacteremia 
can occur after tooth brushing, chewing gum, the use 
of dental floss or spontaneously [17-19]. Moreover, 
many of the microorganisms that are present in the 
oral flora can also be found in the microbiome of the 
upper intestinal tract, making it difficult to identify 
the source. Case reports use the timely association 
between dental procedures and the occurrence of PJI 
as an argument in favour of a causal relationship. 
These arguments are convincing in cases of a virulent 
organism [20]. However, many bacteria of the oral 
flora are considered to have low virulence and hence, 
would cause so-called low-grade PJIs. 
From these results taken together, it can be 
stated that microorganisms of the oral flora can seed 
to an artificial joint, but it is not possible to identify a 
causal relationship with a defined dental procedure 
performed at a specific time. The temporal association 
is a convincing argument in rare cases, but it is not 
proof, as the responsible bacteraemia can occur prior 
to or after the dental procedure. Nonetheless, good 
oral hygiene is associated with a lower risk of PJI [21]. 
Therefore, it is recommended that patients with 
artificial joints maintain good oral hygiene (Table 1). 
Epidemiological considerations 
In their effort to answer an unresolved question, 
doctors frequently raise the need for prospective 
randomized controlled trials. In the case of the current 
question (‘Is antimicrobial prophylaxis needed during 
dental procedures in patients with artificial joints?’), 
however, such a study is not feasible. The trial would 
require several hundred thousand persons with 
artificial joints, comparable numbers and types of 
dental procedures, and follow-up investigations of ≥2 
years [22]. Therefore, recommendations are based on 
retrospective analyses (summarized in [1] and 
supplementary material: Table S1) and case-control 
studies [21, 23, 24].  
PJI after dental procedures are – in consideration 
of the number of patients with artificial joints – 
extremely rare, and hence, not quantifiable. In the 
next sections, we review two epidemiological 
considerations that may offer some answers to the 
present question.  
First, the incidence of hip or knee PJI ranges from 
0.7% [25] to 1.4% [26]. The reported incidence varies, 
however, depending on the observation period, the 
study design and the country in which the study was 
performed. The potential proportion of PJI caused by 
microorganisms belonging to the oral flora is 
frequently less than 4%; few studies report a 
proportion of up to 8% (i.e., absolute incidence of 
<0.028% or <0.1%, respectively) [27-29]. In other 
words, 3 to 10 of 10,000 individuals with an artificial 
joint have a PJI with a microorganism belonging to the 
oral flora. These figures are comparable to those from 
retrospective studies (0.04% in [30], 0.05% in [31]) [1]. 
However, the number of these patients in which PJI 
occurs, irrespective of a dental procedure, remains 
unknown. Thus, antimicrobial prophylaxis would be 
beneficial in only some of these patients because 
haematogenous seeding can occur at any time, even 
without a dental procedure. Even if 80% [32] of the 
above-mentioned 3 to 10 PJI could be prevented with 
antimicrobial prophylaxis, mathematically, this 
means that 1,250 to 4,167 individuals with artificial 
joints must be treated to prevent a single PJI.  
In a second epidemiological consideration, the 
risk of PJI after bacteraemia can be reviewed, given 
the postulated pathogenic mechanism of infection. In 
the case of S. aureus (typically not belonging to the 
oral flora), the risk is high (30%-40%) [33], whereas in 
the case of other microorganisms, the risk is estimated 
to be low (ca. 0.1%) [34]. The potential of 
haematogenous seeding and that of infectiosity is also 
estimated to be low for many bacteria belonging to the 
oral microbiome (e.g., Peptostreptococcus spp., 
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anaerobes). These arguments are relevant because a 
study analysing microorganisms in patients with an 
infected dental root showed that 70% of the 224 
isolates were strict anaerobes or microaerophilic 
bacteria [35]. Ainscow and Denham prospectively 
followed 1,000 individuals after arthroplasty 
implantation for a mean duration of 6 years [36]; 128 
of them had at least one dental intervention during 
the observation period, and none of them developed a 
PJI.  
From these epidemiological considerations, as 
well as from the high frequency of asymptomatic 
transient bacteraemia after daily oral hygiene 
procedures (e.g., tooth brushing, see also below “What 
is the evidence to recommend antimicrobial prophylaxis in 
so-called risk groups?, Type of Dental Procedure”) and 
hence the cumulative haematogenous risk [17, 32], we 
postulate that the risk of PJI after dental procedures is 
markedly low at less than 0.1%. It is possible that 
other reported incidences (calculated retrospectively) 
of 0.1% [37] and 0.2% [38] overestimate the true risk. 
Even with these numbers, and in analogy to the 
mathematical calculation stated earlier, 1,250 or 625 
patients with artificial joints must receive 
antimicrobial prophylaxis to prevent a single PJI [22]. 
Potential adverse events 
Earlier we calculated how many patients had to 
be treated to prevent a single PJI. Consequently, the 
potential of adverse events must be reviewed when 
the same number of patients are treated with 
antibiotics.  
Every antimicrobial therapy is associated with 
collateral damage to the human microbiome. 
Therefore, the use of antimicrobial prophylaxis can 
have an influence on the penicillin susceptibility of 
selected oral streptococci [5, 39-41]. 
The number of known adverse events (allergies 
with various clinical manifestations, nausea, 
diarrhoea, etc.) is clearly higher than the number of 
prevented PJI per 1,000 prescriptions for antimicrobial 
prophylaxis. These side effects occur more frequently 
in elderly individuals [42], namely in the population 
that typically requires an arthroplasty. The same 
argument is valid for Clostridium difficile infections. 
They rarely occur when a single antimicrobial 
prophylaxis is administered, but the risk can increase 
if several dental visits are scheduled within a short 
time [5, 43].  
Considering the numbers needed to treat, it is 
not surprising that antimicrobial prophylaxis during 
dental procedures is not cost-efficient, as 
demonstrated in a recent study with a mathematical 
model (Markov decision modelling) [44]. According 
to an estimation performed in the United States, the 
yearly cost for antimicrobial prophylaxis during 
dental procedures in patients with arthroplasty is 50 
000 000 dollars [5, 45].  
General consensus 
The overall low incidence of PJIs, the low 
proportion of microorganisms belonging to oral flora 
found in PJI, the low risk of haematogenous seeding, 
and the low virulence of these bacteria are arguments 
in favour of not recommending antimicrobial 
prophylaxis during dental procedures in patients with 
artificial joints. Several thousand prescriptions of 
antimicrobial prophylaxis would be required to 
prevent a single PJI. These numbers are clearly higher 
than the numbers known to cause adverse events.  
What is the evidence to recommend 
antimicrobial prophylaxis in so-called 
risk groups? 
Four parameters are frequently cited when 
evaluating variables associated with a higher risk of 
haematogenous PJI after dental procedures: (1) the 
time interval between joint arthroplasty and the 
dental procedure, (2) the immunosuppression/ 
comorbidity of the patient, (3) the type of dental 
procedure, and (4) the duration of the dental 
procedure. Insufficient data (if at all) are available to 
scientifically estimate the risk of PJI on the basis of 
these four parameters. The reasons for nonetheless 
prescribing antimicrobial prophylaxis are, therefore, 
not evidence-based, but frequently based on an 
analogy to other circumstances, hypothetical 
pathogenic mechanisms, or fear of causing an 
infection. 
(1) Time interval between joint arthroplasty 
and the dental procedure 
In the postoperative period of a newly implanted 
arthroplasty, the tissue has been injured from the 
surgery. Hence, the anatomic barriers have not yet 
been completely restored. From a pathogenic point of 
view, the migration of bacteria into the joint during 
bacteraemia is facilitated (i.e., locus minoris 
resistentiae). In parallel to this view, frequency graphs 
have indicated that not only exogenous but also 
haematogenous infections occur more often in the 
first year after implantation than is observed in later 
stages [46]. For these reasons, previous 
recommendations categorized the first 12 [1, 47] to 24 
months [48] after implantation of an arthroplasty as a 
risk period for infection. Counter arguments include 
the fact that large cohort studies have shown a PJI 
incidence of less than 1% in the first year after 
implantation [26] and that of these, among 
haematogenous infections, the proportion of those 
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due to viridans streptococci or anaerobes is 
approximately 4% or less (i.e., absolute ≤0.04%) [49]. 
The time that is required for tissue healing is often 
misinterpreted as the time for achieving good joint 
function. The time required for the latter is estimated 
to be 1 year. It is conceivable that – provided there is 
no reason for impaired tissue healing – the anatomic 
barriers are restored at a much earlier point (e.g., after 
4 to 6 weeks). Because there are no substantial 
scientific grounds to suggest a risk period, we 
categorize – as do our colleagues from Australia 
(supplementary material: Table S1 [50]) – the first 3 
postoperative months to be the risk period (Table 2). 
In future recommendations, when more data become 
available, the duration of this period may be 
shortened. 
(2) Immunosuppression/comorbidity of the 
patient   
Patients treated with immunosuppressive drugs, 
as well as those with diabetes mellitus, rheumatoid 
arthritis, severe liver cirrhosis, haemophilia or other 
diseases associated with severe immunosuppression, 
have an increased risk of infection. An important 
aspect concerning these patients is that the risk is 
increased because of the nature of the disease or 
function of the medication, independent of a dental 
procedure. In reviewing the absolute number of 
individuals with artificial joints, it is not surprising 
that more cases of PJI after dental procedures are 
reported in patients without immunosuppression 
than in immunocompromised hosts [1]. The low 
number of these case reports makes a risk analysis 
impossible. Moreover, many of these comorbidities 
have different stages of severity and other factors 
influencing the risk of infection (doses and type of 
immunosuppression, blood sugar control, duration of 
disease, etc.). Consequently, no recommendation for 
antimicrobial prophylaxis can be made. In the vast 
majority of cases, antimicrobial prophylaxis is not 
justified [51]. We recommend – prior to a dental 
procedure – a discussion of the severity of the disease 
or immunosuppression with the physician managing 
the patient’s comorbidity or immunosuppressive 
drugs. In Switzerland, this is commonly a specialist 
(e.g., oncologist, rheumatologist) and rarely a general 
practitioner. In our view, specialized knowledge is 
required to estimate which disease in what extent 
impairs the host’s immune status. This argument may 
help to judge whether or not elimination of transient 
bacteraemia via the reticulo-endothelial system 
without antimicrobial chemotherapy can be expected. 
In the case of a severe immunosuppressive state (e.g., 
neutropenia due to a haematological malignancy) 
plus other risk factors (Table 2), we recommend 
consultation with a specialist centre prior to the dental 
procedure (Table 3). 
 
 
Table 2. Postulated variables reflecting an increased risk for bacterial haematogenous seeding from the oral cavity to an artificial joint. 
Recommendations in patients without an established infection in the oral cavity. 
 Condition/Recommendation 2nd Condition Recommendation prior 
to dental procedure 
1. Time interval between joint arthroplasty and the dental procedure 
≤ 3 months after implantation Delay dental procedure (if possible) to >3 
months after implantation 
  
Dental procedure cannot be delayed Time interval is the only risk factor Mouth rinse with 0.2% 
chlorhexidine 
Dental procedure cannot be delayed Multiple risk factors Table 3 
2. Immunosuppression/comorbidity of the patient 
Dependent on the severity of the disease or 
level of immunosuppression, respectively  
 
A discussion of the severity of the disease 
or immunosuppression with the physician 
managing the patient’s comorbidity or 
immunosuppressive drugs (e.g., 
oncologist, rheumatologist) 
 
 
 
For many comorbidities, systemic 
antimicrobial prophylaxis is not 
recommended (e.g., diabetes mellitus, 
low-dose treatment with 
corticosteroids) 
Mouth rinse with 0.2% 
chlorhexidine 
Severe immunosuppression (e.g., 
neutropenia due to a haematological 
malignancy, immunosuppressive 
drugs because of solid organ 
transplantation) 
Table 3 
3. Type and duration of dental procedure 
Complex and long dental procedures 
 
As an experience-based opinion, we define 
the term ‘long intervention’ as a dental 
procedure that takes more than 60 minutes 
(no evidence) 
Type and duration is the only risk factor Mouth rinse with 0.2% 
chlorhexidine 
Multiple risk factors Table 3 
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Table 3. Recommendations if multiple risk factors (Table 2) are present. 
Systemic antimicrobial prophylaxis – in addition to mouth rinsing with 0.2% chlorhexidine – should be considered.  
Cases with multiple risk factors are rare (including those in which the dental procedures cannot be delayed). We do not think it is meaningful to publish 
generalizable recommendations on antimicrobial substances for such a minority of patients. 
Multidisciplinary case discussion (including the physician managing the patient’s comorbidity or immunosuppressive drugs, infectious diseases specialist, 
orthopaedic surgeon). 
Consideration of performing the dental procedure at a centre where a corresponding specialist is available. 
 
 
(3) Type of dental procedure 
As mentioned earlier, bacteraemia frequently 
occurs after a dental procedure [10]. After tooth 
extraction, studies have shown a cumulative 
bacteraemia incidence of approximately 60% (33% 
even with antimicrobial prophylaxis). The duration of 
bacteremia is 15 to 20 minutes (in a few patients up to 
60 minutes) [32, 52, 53]. Bacteraemia incidence after 
tooth brushing was 23% [32, 53]. These studies allow 
the following conclusions: Antimicrobial prophylaxis 
may reduce a proportion of bacteraemia but does not 
completely prevent its occurrence. The host’s immune 
status can eliminate this transient bacteraemia via the 
reticulo-endothelial system without antimicrobial 
chemotherapy. Tooth brushing performed multiple 
times a day has a higher cumulative incidence of 
bacteraemia than a single tooth extraction. These 
arguments lead us to question the benefit of systemic 
antimicrobial prophylaxis. A complex dental 
intervention may have a higher risk of bacteraemia, 
although, in the same line of reasoning, a complex 
intervention alone does not justify systemic 
antimicrobial prophylaxis.  
Studies have shown that the bacteraemia 
incidence after tooth extraction can be reduced via 
pre-interventional mouth rinsing with 0.2% 
chlorhexidine in comparison to placebo (after 15 to 20 
minutes, 23% versus 4%, p = 0.005 in [52]; 64% versus 
30%, p < 0.001 in [54]). This magnitude of risk 
reduction is comparable to that when systemic 
antimicrobial prophylaxis is administered [1, 32]. 
Therefore, we recommend pre-interventional mouth 
rinsing with 0.2% chlorhexidine, including when 
tooth extraction or complex dental interventions is 
planned (Table 2). 
(4) Duration of dental procedure 
In analogy to all surgical interventions, it seems 
logical that the longer the duration of the intervention, 
the higher the risk of infection. However, for dental 
procedures, there is no cut-off time that is associated 
with a higher risk of infection, and the time term 
‘long’ is not defined. One series described three 
patients with PJI after a dental procedure, all of whom 
had a dental intervention of ≥45 minutes [37]. In 
another case series consisting of nine patients with PJI 
after a dental procedure, the intervention time ranged 
from 75 to 205 minutes [38]. On the basis of these 
experiences, in previous recommendations, a dental 
intervention that took more than 45 minutes was 
classified as an intervention with a higher risk of 
infection. A statistically significant association is not 
possible with these small numbers. An argument 
against such fixed time cut-offs for risk classification 
is the observation of a study in which a small 
proportion of volunteers (<5%) still had bacteraemia 
even 60 minutes after tooth brushing [32].  
Although it is arbitrary and without evidence, as 
an experience-based opinion, we define the term ‘long 
intervention’ as a dental procedure that takes more 
than 60 minutes. This recommendation has no 
scientific background. However, a routine dental 
procedure rarely takes longer than 60 minutes. 
Consensus statement regarding 
antimicrobial prophylaxis in so-called 
risk groups 
In our view, none of these conditions previously 
classified as risk factors justifies as a single parameter 
the use of systemic antimicrobial prophylaxis for 
dental procedures. In rare cases, a patient may have 
multiple risk factors (e.g., triple immunosuppression 
because of a lung transplant plus hip arthroplasty 3 
months ago plus a complex dental procedure that 
takes more than 60 minutes). Although some experts 
would consider the use of antimicrobial prophylaxis 
in these rare cases, we do not think it is meaningful to 
publish generalizable recommendations on 
antimicrobial substances for such a minority of 
patients. We recommend discussing these cases with a 
specialist centre and consideration of performing the 
dental procedure at a centre where a corresponding 
specialist is available (Table 3).  
Supplementary Material  
Supplementary table S1. 
http://www.jbji.net/v01p0042s1.pdf 
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